Bone Biologics announces annual shareholder meeting
BBLG•Annual shareholder meeting and ballot items
Bone Biologics will hold its annual shareholder meeting in Burlington, Massachusetts, on Sept. 28, 2026.
Shareholders will vote to elect four directors.
An advisory vote on executive compensation is scheduled, alongside ratification of Weinberg & Company as auditor for 2026.
Ballots also cover potential share issuance tied to outstanding warrants from a private placement.
Investors will vote on a reverse stock split within a 1-for-2 to 1-for-10 range, with authority to adjourn if needed.
